MaxCyte Inc
NASDAQ:MXCT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of MaxCyte Inc (MXCT) under the Base Case is 1.69 USD per share. Compared with the current market price of 1.13 USD, the stock appears Undervalued by 33% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What MaxCyte Does
MaxCyte sells cell-engineering tools that let scientists and drug makers move DNA, RNA, proteins, and other material into living cells. Its main product is an electroporation platform, along with disposable cartridges and related support services. The company’s customers are biotech and pharmaceutical firms, especially teams developing cell therapies and gene-edited medicines, as well as research labs that need reliable ways to modify cells.
- Headquarters
- United States of America US
- Employees
- 91
- IPO date
- Mar 29, 2016
Earnings Waterfall
MaxCyte Inc
What is the Intrinsic Value of one MXCT stock?
The intrinsic value for MaxCyte Inc (MXCT) under the Base Case is 1.69 USD.
Is MXCT stock undervalued or overvalued?
Compared with the current market price of 1.13 USD, the stock appears Undervalued by 33% .